Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

ChemoCentryx, Inc. (CCXI)

-NasdaqGS
5.64 0.12(2.17%) Jul 25, 4:00PM EDT
Prev Close:5.52
Open:5.44
Bid:5.43 x 800
Ask:5.75 x 100
1y Target Est:8.33
Beta:0
Next Earnings Date: 5-Aug-14CCXI Earnings announcement
Day's Range:5.44 - 5.71
52wk Range:4.57 - 14.09
Volume:65,963
Avg Vol (3m):147,267
Market Cap:243.94M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CCXI

Comparison

Symbol% ChgMkt Cap
CCXIUp 2.17%243.94M
ABT64.64B
AMGN92.99B
AZN93.92B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):57.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.10
Quarterly EPS Est (Jun-14) :-0.27
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback